Week brief · July 20 to 26, 2026
Biotech news, week of July 20, 2026
In the week of July 20 to 26, 2026 the Biotech desk recorded 20 news events on 6 days. Pharma led with 9.
- news events20
- outlet reports33
- days with news6
- carried by 5+ outlets0
The most covered stories of the week
- Jul 20 Study links several hormonal contraceptives to meningioma risk 3
- Jul 20 India approves first dengue vaccine QDENGA after DCGI clearance 2
- Jul 20 Medtrum reports progress toward German launch of 300U patch pump 2
- Jul 20 montrealgazette.com: “Galderma Launches Alastin® in Japan and Key Markets Across Asia Pacific, Expanding Its Footprint in the Region” 2
- Jul 21 miragenews.com: “Pregnancy Complications Linked to Higher Artery Risk” 2
- Jul 21 Menarini Asia-Pacific and Pharmacosmos partner on Cosela in Asia 2
- Jul 22 sandiegouniontribune.com: “San Diego biotechs outperform San Francisco but cant raise money – San Diego Union” 2
- Jul 23 vtcng.com: “Lawmakers debate GLP - 1 regulation, expansion” 2
- Jul 23 FDA panel narrowly backs unapproved peptide drugs 2
Monday, July 20, 2026
6 events. The full rundown for July 20, 2026. The most covered:
Tuesday, July 21, 2026
-
01
Coverage recordmiragenews.com: “Pregnancy Complications Linked to Higher Artery Risk”
The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).
Reported by Mirage News and MedPage Today.
- Peripheral Artery Disease (PAD)
-
02
Menarini Asia-Pacific and Pharmacosmos partner on Cosela in Asia
Machine summary Menarini Asia-Pacific and Pharmacosmos have partnered to bring the oncology supportive care therapy Cosela to patients in Asia, according to the two reports. The reports describe Cosela as a first-in-class therapy.
- Menarini Asia-Pacific and Pharmacosmos partnered to bring Cosela to Asian patients, according to the reports.
- The reports describe Cosela as a first-in-class oncology supportive care therapy.
Reported by The Hindu and vietnamtribune.com (Big News Network).
- Cosela (trilaciclib)
- Menarini Asia-Pacific
-
03
Coverage recordiHeartRadio: “Allergy Medication Recalled Over Potential Cross - Contamination”
The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).
Reported by iHeartRadio.
Wednesday, July 22, 2026
-
04
Coverage recordsandiegouniontribune.com: “San Diego biotechs outperform San Francisco but cant raise money – San Diego Union”
Reports ran between 14:00 and 21:30 UTC on Jul 22.
The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).
Reported by sandiegouniontribune.com and siliconvalley.com.
- San Diego
-
05
Lula signs law on Brazil medicines and vaccine production
Machine summary brazilsun.com reports that Brazilian President Lula signed a law aimed at strengthening the country’s sovereignty in medicines and vaccine production.
- Lula signed a law to strengthen Brazil sovereignty in medicines and vaccine production, according to reports.
Reported by brazilsun.com (Big News Network) and argentinastar.com (Big News Network).
-
06
Experts say proposed US generic drug tariffs are out of scope
Machine summary Experts commented on proposed US tariffs on generic drugs after US President Donald Trump announced the plan, according to reports. Pharmexcil chairman Namit Joshi said the tariffs are out of scope and difficult to absorb, while Indian Pharmaceutical Alliance secretary general Sudarshan Jain said the group will continue to engage with the US administration.
- US President Donald Trump announced a proposed policy on generic drug tariffs, according to reports.
- Pharmexcil chairman Namit Joshi said the announced tariffs are out of scope and that the Indian industry does not have enough margin to absorb them.
- Entod Pharmaceuticals CEO Nikkhil K Masurkar said India should eye being the healthcare leader for the Global South.
Reported by heraldglobe.com (Big News Network) and milwaukeesun.com (Big News Network).
- Donald Trump
- generic drugs
- Pharmexcil
- Indian Pharmaceutical Alliance (IPA)
Thursday, July 23, 2026
-
07
Coverage recordvtcng.com: “Lawmakers debate GLP - 1 regulation, expansion”
Reports ran between 00:00 and 01:45 UTC on Jul 23.
The outlets that reported this event are listed with links to their reports; no summary of ours passed our automated checks for it, which says nothing about the event (how they work).
Reported by vtcng.com and sanfordherald.com.
-
08
FDA panel narrowly backs unapproved peptide drugs
Machine summary An FDA panel narrowly backed unapproved peptide drugs, according to NBC New York and NBC 5 Dallas-Fort Worth.
- An FDA panel narrowly backed unapproved peptide drugs, according to NBC New York.
- NBC 5 Dallas-Fort Worth reported that an FDA panel narrowly backed unapproved peptide drugs.
Reported by nbcnewyork.com and nbcdfw.com.
-
09
Genmab and AbbVie clarify EPCORE DLBCL-1 primary endpoint results
Machine summary Genmab A/S and AbbVie provided clarification on the primary endpoints of the Phase 3 EPCORE DLBCL-1 trial of monotherapy epcoritamab in adults with relapsed or refractory diffuse large B-cell lymphoma who were ineligible for autologous stem cell transplantation.
- Genmab and AbbVie said the Phase 3 EPCORE DLBCL-1 trial has prespecified primary endpoints that differ by region.
Reported by finanznachrichten.de and stockhouse.com.
- AbbVie
- epcoritamab
- Genmab
- EPCORE DLBCL-1
Friday, July 24, 2026
-
10
eXoZymes selected for DoE Genesis Mission
Machine summary eXoZymes was selected for the Department of Energy's Genesis Mission to advance AI-powered digital twins for cell-free biomanufacturing, according to reports.
- eXoZymes was selected for the DoE Genesis Mission, according to reports.
- The selection is to advance AI-powered digital twins for cell-free biomanufacturing, according to reports.
Reported by hawaiitelegraph.com (Big News Network) and californiatelegraph.com (Big News Network).
- Genesis Mission
- AI-powered digital twins
- eXoZymes Inc.
More events reported
No summary of ours and no outlet headline passed our automated checks for these, which says nothing about the events (how they work); the outlets and their reports are linked.
Tuesday, July 21, 2026
- · 2 outletsmedicalnewstoday.com, irishdentist.ie
Thursday, July 23, 2026
Sunday, July 26, 2026
- · 2 outletschannelnewsasia.com, straitstimes.com
Summaries and key facts are machine summaries of the reports linked with them; outlets, times and counts come from those reports. How a rundown is built.
What kind of news was it?
Sources: the outlets' reports linked on this page; counts and times from GetYourBrief's record of those reports (methodology).